Citations (268)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (29)
Giovanni Corona, Giulia Rastrelli, Linda Vignozzi, Arcangelo Barbonetti, Alessandra Sforza, Edoardo Mannucci & Mario Maggi. (2021) The Role of testosterone treatment in patients with metabolic disorders. Expert Review of Clinical Pharmacology 14:9, pages 1091-1103.
Read now
Read now
Ahmad Al-Qudimat, Raed M. Al-Zoubi, Aksam A. Yassin, Mustafa Alwani, Omar M. Aboumarzouk, Khaled AlRumaihi, Raidh Talib & Abdulla Al Ansari. (2021) Testosterone treatment improves liver function and reduces cardiovascular risk: A long-term prospective study. Arab Journal of Urology 19:3, pages 376-386.
Read now
Read now
Aksam A. Yassin, Mustafa Alwani, Riadh Talib, Yousef Almehmadi, Joanne E. Nettleship, Khalid Alrumaihi, Bassam Albaba, Daniel M. Kelly & Farid Saad. (2020) Long-term testosterone therapy improves liver parameters and steatosis in hypogonadal men: a prospective controlled registry study. The Aging Male 23:5, pages 1553-1563.
Read now
Read now
Monica Caliber & Geoff Hackett. (2020) Important lessons about testosterone therapy- weight loss vs. testosterone therapy for symptom resolution, classical vs. functional hypogonadism, and shortterm vs. lifelong testosterone therapy. The Aging Male 23:5, pages 585-591.
Read now
Read now
Elżbieta Kalicińska, Katarzyna Wojtas, Jacek Majda, Maciej Zacharski, Jacek Skiba, Jan Śliwowski, Waldemar Banasiak, Piotr Ponikowski & Ewa A. Jankowska. (2020) Expression of sex steroid receptors and aromatase in adipose tissue in different body regions in men with coronary artery disease with and without ischemic systolic heart failure. The Aging Male 23:2, pages 141-153.
Read now
Read now
L. Y. Morgunov, I. A. Denisova, T. I. Rozhkova, L. V. Stakhovskaya & V. I. Skvortsova. (2020) Hypogonadism and its treatment following ischaemic stroke in men with type 2 diabetes mellitus. The Aging Male 23:1, pages 71-80.
Read now
Read now
Chunhua Deng, Zhichao Zhang, Hongjun Li, Peng Bai, Xian Cao & Adrian Sandra Dobs. (2019) Analysis of cardiovascular risk factors associated with serum testosterone levels according to the US 2011–2012 National Health and Nutrition Examination Survey. The Aging Male 22:2, pages 121-128.
Read now
Read now
Kristina Groti, Ivan Žuran, Blaž Antonič, Lidija Foršnarič & Marija Pfeifer. (2018) The impact of testosterone replacement therapy on glycemic control, vascular function, and components of the metabolic syndrome in obese hypogonadal men with type 2 diabetes. The Aging Male 21:3, pages 158-169.
Read now
Read now
Jason Kovac, Alexander W. Pastuszak, Dolores J. Lamb & Larry I. Lipshultz. (2014) Testosterone Supplementation Therapy in the Treatment of Patients with Metabolic Syndrome. Postgraduate Medicine 126:7, pages 149-156.
Read now
Read now
A. Afiadata & Pamela Ellsworth. (2014) Testosterone Replacement Therapy: Who to Evaluate, What to Use, How to Follow, and Who is at Risk?. Hospital Practice 42:5, pages 69-82.
Read now
Read now
Felice Strollo, Giovanna Strollo, Massimo Morè, Paolo Magni, Chiara Macchi, Maria Angela Masini, Iarba Carucci, Fabio Celotti, Massimiliano Ruscica & Sandro Gentile. (2013) Low-intermediate dose testosterone replacement therapy by different pharmaceutical preparations improves frailty score in elderly hypogonadal hyperglycaemic patients. The Aging Male 16:2, pages 33-37.
Read now
Read now
Olavi Ukkola, Tuomas Huttunen, Veli-Pekka Puurunen, Olli-Pekka Piira, Jarkko Niva, Samuli Lepojärvi, Mikko Tulppo & Heikki Huikuri. (2013) Total testosterone levels, metabolic parameters, cardiac remodeling and exercise capacity in coronary artery disease patients with different stages of glucose tolerance. Annals of Medicine 45:3, pages 206-212.
Read now
Read now
Gary Blick. (2013) Optimal Diagnostic Measures and Thresholds for Hypogonadism in Men With HIV/AIDS: Comparison Between 2 Transdermal Testosterone Replacement Therapy Gels. Postgraduate Medicine 125:2, pages 30-39.
Read now
Read now
Martin M. Miner, Rajib K. Bhattacharya, Gary Blick, Harvey Kushner & Mohit Khera. (2013) 12-Month Observation of Testosterone Replacement Effectiveness in a General Population of Men. Postgraduate Medicine 125:2, pages 8-18.
Read now
Read now
Hermann M. Behre, Teuvo L. J. Tammela, Stefan Arver, Josep R. Tolrá, Vincenzo Bonifacio, Michael Lamche, Judy Kelly, Florian Hiemeyer, Erik J. Giltay & Louis J. Gooren. (2012) A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up. The Aging Male 15:4, pages 198-207.
Read now
Read now
Jian Cao, Jian Li, Weijun Hao, Xiaoying Li, Hao Wang, Lin Liu, Bingpo Zhu & Zhiqin Guo. (2011) Correlation of sex hormone and androgen receptor with diabetes mellitus in elderly men. The Aging Male 14:3, pages 162-167.
Read now
Read now
G.E. Jensen, N.G. Nikolov, E.B. Wedebye, T. Ringsted & J.R. Niemelä. (2011) QSAR models for anti-androgenic effect – a preliminary study. SAR and QSAR in Environmental Research 22:1-2, pages 35-49.
Read now
Read now
Atoosa Rabiee, Andrew A. Dwyer, Lisa M. Caronia, Frances J. Hayes, Maria A. Yialamas, Dana K. Andersen, Bijoy Thomas, Martin Torriani & Dariush Elahi. (2010) Impact of Acute Biochemical Castration on Insulin Sensitivity in Healthy Adult Men. Endocrine Research 35:2, pages 71-84.
Read now
Read now
Jo Anne B Farrell, Anjali Deshmukh & Ali A Baghaie. (2010) Androgen deficiency in males. Expert Review of Endocrinology & Metabolism 5:2, pages 265-272.
Read now
Read now
Yun Chen, Yutian Dai & Run Wang. (2008) Treatment strategies for diabetic patients suffering from erectile dysfunction. Expert Opinion on Pharmacotherapy 9:2, pages 257-266.
Read now
Read now
Martin Miner, David J. Canty & Ridwan Shabsigh. (2008) Testosterone Replacement Therapy in Hypogonadal Men: Assessing Benefits, Risks, and Best Practices. Postgraduate Medicine 120:3, pages 130-153.
Read now
Read now
Roger D Stanworth & T Hugh Jones. (2008) Testosterone for the aging male; current evidence and recommended practice
. Clinical Interventions in Aging 3:1, pages 25-44.
Read now
Read now
G. Corona, G. Forti & M. Maggi. (2008) Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. The Aging Male 11:4, pages 193-199.
Read now
Read now
Andrea Fabbri, Andrea M Isidori, Elisa Giannetta & Andrea Lenzi. (2007) Testosterone treatment to mimic hormone physiology in androgen replacement therapy. Expert Opinion on Biological Therapy 7:7, pages 1093-1106.
Read now
Read now
Bruno Lunenfeld$suffix/text()$suffix/text(). (2007) Testosterone deficiency and the metabolic syndrome. The Aging Male 10:2, pages 53-56.
Read now
Read now
Frank Michael Köhn. (2006) Testosterone and body functions. The Aging Male 9:4, pages 183-188.
Read now
Read now
B Lunenfeld, F Saad & CE Hoesl. (2005) ISA, ISSAM and EAU recommendations for the investigation, treatment and monitoring of late-onset hypogonadism in males: Scientific background and rationale. The Aging Male 8:2, pages 59-74.
Read now
Read now
Walter Krause, Ulrich Mueller & Allan Mazur. (2005) Testosterone supplementation in the aging male: Which questions have been answered?. The Aging Male 8:1, pages 31-38.
Read now
Read now
M. Oettel. (2003) Testosterone metabolism, dose–response relationships and receptor polymorphisms: selected pharmacological/toxicological considerations on benefits versus risks of testosterone therapy in men. The Aging Male 6:4, pages 230-256.
Read now
Read now
Articles from other publishers (239)
Zuzanna Karbowska, Katarzyna Cierpiszewska, Klara Maruszczak, Ivanna Sukhachova, Dominika Szwankowska & Igor Piotrowski. (2023) Impact of testosterone levels and testosterone replacement ther-apy on men’s health. Journal of Medical Science, pages e856.
Crossref
Crossref
Grant R. Laskin, Jennifer L. Steiner, Claire E. Berryman & Bradley S. Gordon. (2023) SIRT1 induction in the skeletal muscle of male mice partially attenuates changes to whole-body metabolism in response to androgen deprivation. Biochemical and Biophysical Research Communications 682, pages 124-131.
Crossref
Crossref
Joe Rizk, Rajesh Sahu & Delphine Duteil. (2023) An overview on androgen-mediated actions in skeletal muscle and adipose tissue. Steroids, pages 109306.
Crossref
Crossref
E. A. Troshina & Р. A. Terekhov. (2023) Hypogonadism and visceral obesity in men are full–fledged components of the metabolic syndrome. Obesity and metabolism 20:1, pages 84-91.
Crossref
Crossref
Di Zhang, Jingjing Fan, Hui Liu, Guobin Qiu & Sheng Cui. (2023) Testosterone enhances taurine synthesis by upregulating androgen receptor and cysteine sulfinic acid decarboxylase expressions in male mouse liver. American Journal of Physiology-Gastrointestinal and Liver Physiology 324:4, pages G295-G304.
Crossref
Crossref
Jake A Miller, Tuan T Nguyen, Charles Loeb, Mohit Khera & Faysal A Yafi. (2023) Oral testosterone therapy: past, present, and future. Sexual Medicine Reviews.
Crossref
Crossref
Jothydev Kesavadev, Fatema Jawad, Asma Deeb, Ankia Coetzee, M. A. Jalil Ansari, Dina Shrestha, Noel Somasundaram & Sanjay Kalra. 2023. The Diabetes Textbook. The Diabetes Textbook
127
142
.
Saeed M. Omar, Imad R. Musa, Maysoon B. Idrees, Omer Abdelbagi & Ishag Adam. (2022) Prevalence and associated factors of erectile dysfunction in men with type 2 diabetes mellitus in eastern Sudan. BMC Endocrine Disorders 22:1.
Crossref
Crossref
Nirja Kaka, Yashendra Sethi, Neil Patel, Okashah Kaiwan, Yana Al-Inaya, Kshitij Manchanda & Nidhi Uniyal. (2022) Endocrine manifestations of chronic kidney disease and their evolving management: A systematic review. Disease-a-Month 68:12, pages 101466.
Crossref
Crossref
Marià Alemany. (2022) The Roles of Androgens in Humans: Biology, Metabolic Regulation and Health. International Journal of Molecular Sciences 23:19, pages 11952.
Crossref
Crossref
Jessica N. Schardein & James M. Hotaling. (2022) The Impact of Testosterone on Erectile Function. Androgens: Clinical Research and Therapeutics 3:1, pages 113-124.
Crossref
Crossref
Mahesh Umapathysivam, Mathis Grossmann & Gary A. Wittert. (2022) Effects of androgens on glucose metabolism. Best Practice & Research Clinical Endocrinology & Metabolism 36:5, pages 101654.
Crossref
Crossref
Satesh Kumar, Mahima Khatri, Rahat Ahmed Memon, Jordan Llerena Velastegui, Kristina Zumbana Podaneva, Daniela Benitez Gutierrez, Bilawal Nadeem, Akhil Raj Anumolu, Masood Azhar & Ahmad Zain. (2022) Effects of testosterone therapy in adult males with hypogonadism and T2DM: A meta-analysis and systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16:8, pages 102588.
Crossref
Crossref
Giuseppe Fallara, Edoardo Pozzi, Christian Corsini, Federico Belladelli, Luca Boeri, Paolo Capogrosso, Francesco Montorsi & Andrea Salonia. (2022) Morbidity and mortality in men: Role of androgens. Best Practice & Research Clinical Endocrinology & Metabolism 36:4, pages 101662.
Crossref
Crossref
Wonder Yao NANEVI, Monday MOSES, Emmanuel ANSU GYEABOUR & Robert Junior BOATENG. (2022) Postural stability, body composition and functional ability of the lower extremity in patients with lumbar degenerative spondylolisthesis. Turkish Journal of Kinesiology 8:2, pages 44-49.
Crossref
Crossref
Varun S. Venkatesh, Mathis Grossmann, Jeffrey D. Zajac & Rachel A. Davey. (2022) The role of the androgen receptor in the pathogenesis of obesity and its utility as a target for obesity treatments. Obesity Reviews 23:6.
Crossref
Crossref
Catherine H. Marshall, Jessa Tunacao, Varun Danda, Hua‐Ling Tsai, John Barber, Rakhee Gawande, Clifford R. Weiss, Samuel R. Denmeade & Corinne Joshu. (2021) Reversing the effects of androgen‐deprivation therapy in men with metastatic castration‐resistant prostate cancer. BJU International 128:3, pages 366-373.
Crossref
Crossref
Xiaowei Yu, Zhentong Wei, Yanhong Liu, XiaoYuan Zhang & Qun Wang. (2021) Effects of Testosterone Replacement Therapy on Glycolipid Metabolism Among Hypogonadal Men withT2DM: A Meta-Analysis And System Review Of Randomized Controlled Trials. Sexual Medicine 9:4, pages 100403-100403.
Crossref
Crossref
Naina Kumari, Anoosha Khan, Usman Shaikh, Kimberly Lobes, Deepak Kumar, FNU Suman, Naila S Bhutto, Faryal Anees, Simra Shahid & Amber Rizwan. (2021) Comparison of Testosterone Levels in Patients With and Without Type 2 Diabetes. Cureus.
Crossref
Crossref
Ngamariju Sepu, Jokotade O. Adeleye & Modupe O. Kuti. (2021) Serum testosterone in Nigerian men with type 2 diabetes mellitus and its relationship with insulin sensitivity and glycemic control. Journal of the National Medical Association 113:3, pages 285-293.
Crossref
Crossref
Sasikala M. Chinnappan, Annie George, Pragya Pandey, Govinda Narke & Yogendra Kumar Choudhary. (2021) Effect of Eurycoma longifolia standardised aqueous root extract–Physta® on testosterone levels and quality of life in ageing male subjects: a randomised, double-blind, placebo-controlled multicentre study. Food & Nutrition Research 65.
Crossref
Crossref
Zachary L. Sebo & Matthew S. Rodeheffer. (2021) Testosterone metabolites differentially regulate obesogenesis and fat distribution. Molecular Metabolism 44, pages 101141.
Crossref
Crossref
Vittoria Russo, Rui Chen & Reina Armamento-Villareal. (2021) Hypogonadism, Type-2 Diabetes Mellitus, and Bone Health: A Narrative Review. Frontiers in Endocrinology 11.
Crossref
Crossref
Zhichao Zhang, Deying Kang & Hongjun Li. (2020) The effects of testosterone on bone health in males with testosterone deficiency: a systematic review and meta-analysis. BMC Endocrine Disorders 20:1.
Crossref
Crossref
William T. Berg & Martin Miner. (2020) Hypogonadism and metabolic syndrome: review and update. Current Opinion in Endocrinology, Diabetes & Obesity 27:6, pages 404-410.
Crossref
Crossref
Nde Zacharie, Massoma Lembè Dieudonné, Wankeu Nya Modeste, Ngaha Marie Ide, Koloko Brice Landry, Bend Emma, Etaga Noël, Mbock Armel, Toham Yebga, Mboumwa Paul Valerie G & Nyonseu Nzeubang Doriane Camille. (2020) Potential activity of Aframomum daniellii (Zingiberaceae) dry seeds: A case study of its action mechanism on the Wistar rat strain with testicular deficiency. Biomedicine & Pharmacotherapy 131, pages 110759.
Crossref
Crossref
Shu-ying Li, Ya-ling Zhao, Yu-fan Yang, Xi Wang, Min Nie, Xue-yan Wu, Jiang-feng Mao & Franco Veglio. (2020) Metabolic Effects of Testosterone Replacement Therapy in Patients with Type 2 Diabetes Mellitus or Metabolic Syndrome: A Meta-Analysis. International Journal of Endocrinology 2020, pages 1-12.
Crossref
Crossref
Zelal Jaber Kharaba, Manal Ali Buabeid, Nihal A. Ibrahim, Feras Jassim Jirjees, Hala Jehad Al Obaidi, Adnan Kaddaha, Laleh Khajehkarimoddini & Yassen Alfoteih. (2020) Testosterone therapy in hypogonadal patients and the associated risks of cardiovascular events. Biomedicine & Pharmacotherapy 129, pages 110423.
Crossref
Crossref
Rabia Farooq, Mohammad Hayat Bhat, Sabhiya Majid & Mohammad Muzaffar Mir. (2020) Association between T2DM and the lowering of testosterone levels among Kashmiri males. Archives of Endocrinology and Metabolism.
Crossref
Crossref
Kashif Shaikh, Susan S Ellenberg, Rine Nakanishi, Peter J Snyder, Juhwan Lee, Nanette K Wenger, Cora E Lewis, Ronald S Swerdloff, Peter Preston, Sajad Hamal, Alisa Stephens-Sheilds, Shalender Bhasin, Lavanya Cherukuri, Jane A Cauley, Jill P Crandall, Glenn R Cunningham, Kristine E Ensrud, Alvin M Matsumoto, Mark E Molich, Venkata M Alla, Divya Birudaraju, Negin Nezarat, Kelash Rai, Shone Almeida, Sion K Roy, Mohammad Sheikh, George Trad & Mathew J Budoff. (2020) Biomarkers and Noncalcified Coronary Artery Plaque Progression in Older Men Treated With Testosterone. The Journal of Clinical Endocrinology & Metabolism 105:7, pages 2142-2149.
Crossref
Crossref
Norbert Stefan. (2020) Causes, consequences, and treatment of metabolically unhealthy fat distribution. The Lancet Diabetes & Endocrinology 8:7, pages 616-627.
Crossref
Crossref
Konstantinos Dimitropoulos, Paolo Verze, Thomas Van den Broeck, Andrea Salonia, Cathy Yuhong Yuan, Konstantinos Hatzimouratidis & Gert Dohle. (2019) What are the benefits and harms of testosterone therapy for male sexual dysfunction?—a systematic review. International Journal of Impotence Research 31:6, pages 380-391.
Crossref
Crossref
Aaron P. Frank, Roberta de Souza Santos, Biff F. Palmer & Deborah J. Clegg. (2019) Determinants of body fat distribution in humans may provide insight about obesity-related health risks. Journal of Lipid Research 60:10, pages 1710-1719.
Crossref
Crossref
Thiago Gagliano-Jucá & Shehzad Basaria. (2019) Testosterone replacement therapy and cardiovascular risk. Nature Reviews Cardiology 16:9, pages 555-574.
Crossref
Crossref
Wang Junjie, Hao Dongsheng, Sun Lei, Li Hongzhuo & Sun Changying. (2019) Testosterone Replacement Therapy Has Limited Effect on Increasing Bone Mass Density in Older Men: a Meta-analysis. Current Pharmaceutical Design 25:1, pages 73-84.
Crossref
Crossref
Ahmet Tevfik Albayrak & Ege Can Serefoglu. 2019. Effects of Lifestyle on Men's Health. Effects of Lifestyle on Men's Health
149
168
.
Abdulmaged M. Traish & Abraham Morgentaler. 2019. Sex Differences in Cardiovascular Physiology and Pathophysiology. Sex Differences in Cardiovascular Physiology and Pathophysiology
321
354
.
Jothydev Kesavadev, Fatema Jawad, Asma Deeb, Ankia Coetzee, M. A. Jalil Ansari, Dina Shrestha, Noel Somasundaram & Sanjay Kalra. 2019. The Diabetes Textbook. The Diabetes Textbook
101
116
.
Yonghua Jiang, Juan Ye, Mukun Zhao, Aihua Tan, Haiying Zhang, Yong Gao, Zheng Lu, Chunlei Wu, Yanling Hu, Qiuyan Wang, Xiaobo Yang & Zengnan Mo. (2018) Cross-sectional and longitudinal associations between serum testosterone concentrations and hypertension: Results from the Fangchenggang Area Male Health and Examination Survey in China. Clinica Chimica Acta 487, pages 90-95.
Crossref
Crossref
André Tchernof, Dannick Brochu, Ina Maltais‐Payette, Mohamed Fouad Mansour, Geneviève B. Marchand, Anne‐Marie Carreau & Jordanna Kapeluto. 2011. Comprehensive Physiology. Comprehensive Physiology
1253
1290
.
Jianzhong Zhang, Bin Yang, Wenhui Xiao, Xiao Li & Hongjun Li. (2018) Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review. World Journal of Urology 36:8, pages 1315-1326.
Crossref
Crossref
Richard Bebb, Adam Millar & Gerald Brock. (2018) Sexual Dysfunction and Hypogonadism in Men With Diabetes. Canadian Journal of Diabetes 42, pages S228-S233.
Crossref
Crossref
Ahmed I. El-Sakka. (2018) Dehydroepiandrosterone and Erectile Function: A Review. The World Journal of Men's Health 36:3, pages 183.
Crossref
Crossref
K.-S. Zhang, M.-J. Zhao, Q. An, Y.-F. Jia, L.-L. Fu, J.-F. Xu & Y.-Q. Gu. (2018) Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials. Andrology 6:1, pages 37-46.
Crossref
Crossref
Abdulmaged M. Traish. (2018) Benefits and Health Implications of Testosterone Therapy in Men With Testosterone Deficiency. Sexual Medicine Reviews 6:1, pages 86-105.
Crossref
Crossref
M.H. Colson, B. Cuzin, A. Faix, L. Grellet & E. Huyghes. (2018) La dysfonction érectile du diabétique. Sexologies 27:1, pages 53-58.
Crossref
Crossref
Ashot M. Mkrtumyan & Lilit V. Egshatyan. (2017) Influence of androgen deficiency on carbohydrate metabolism in men. Obesity and metabolism 14:3, pages 19-24.
Crossref
Crossref
Yu Wang, Yang Hu, Zhaoping Zeng, Yinghua Li, Huipeng Su, Yiwei Li, Ruiping Wang, Mingqian Zhang, Yongli Yang & Jie Deng. (2017) Influence of androgen on myocardial apoptosis and expression of myocardial IR and IRS‑1 in chronic heart failure rat models. Molecular Medicine Reports.
Crossref
Crossref
Abdulmaged M. Traish, Ahmad Haider, Karim Sultan Haider, Gheorghe Doros & Farid Saad. (2017) Long-Term Testosterone Therapy Improves Cardiometabolic Function and Reduces Risk of Cardiovascular Disease in Men with Hypogonadism. Journal of Cardiovascular Pharmacology and Therapeutics 22:5, pages 414-433.
Crossref
Crossref
Michael L. Schulster, Sydney E. Liang & Bobby B. Najari. (2017) Metabolic syndrome and sexual dysfunction. Current Opinion in Urology 27:5, pages 435-440.
Crossref
Crossref
S. I. Onung, E. E. Young, T. E. Ugwu & O. A. Fasanmade. (2016) Hypogonadism in Nigerian men with type 2 diabetes mellitus. International Journal of Diabetes in Developing Countries 37:3, pages 254-261.
Crossref
Crossref
Prita R. Asih, Michelle L. Tegg, Hamid Sohrabi, Malcolm Carruthers, Samuel E. Gandy, Farid Saad, Giuseppe Verdile, Lars M. Ittner & Ralph N. Martins. (2017) Multiple Mechanisms Linking Type 2 Diabetes and Alzheimer’s Disease: Testosterone as a Modifier. Journal of Alzheimer's Disease 59:2, pages 445-466.
Crossref
Crossref
C.L. Pankey, M.W. Walton, J.F. Odhiambo, A.M. Smith, A.B. Ghnenis, P.W. Nathanielsz & S.P. Ford. (2017) Intergenerational impact of maternal overnutrition and obesity throughout pregnancy in sheep on metabolic syndrome in grandsons and granddaughters. Domestic Animal Endocrinology 60, pages 67-74.
Crossref
Crossref
Pawel J. Wiechno, Grazyna M. Poniatowska, Wojciech Michalski, Jakub Kucharz, Malgorzata Sadowska, Joanna Jonska-Gmyrek, Karol Nietupski, Joanna Rzymowska & Tomasz Demkow. (2017) Clinical significance of androgen secretion disorders in men with a malignancy. Medical Oncology 34:7.
Crossref
Crossref
Dana Stoian, Ioana Mozos, Marius Craina, Corina Paul, Iulian Velea, Adalbert Schiller & Mihaela Craciunescu. 2017. Sexual Dysfunction. Sexual Dysfunction.
L. Lašaitė, J. Čeponis, R. T. Preikša & B. Žilaitienė. (2017) Effects of two-year testosterone replacement therapy on cognition, emotions and quality of life in young and middle-aged hypogonadal men. Andrologia 49:3, pages e12633.
Crossref
Crossref
Geoffrey I. Hackett. 2017. Diabetes in Old Age. Diabetes in Old Age
148
166
.
J.P. Dias, M. D. Shardell, O. D. Carlson, D. Melvin, G. Caturegli, L. Ferrucci, C. W. Chia, J. M. Egan & S. Basaria. (2017) Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters. Andrology 5:1, pages 31-40.
Crossref
Crossref
Farid Saad. 2017. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
527
558
.
Mohamed Fouad Mansour, Chon-Wai Jeremy Chan, Sofia Laforest, Alain Veilleux & André Tchernof. 2017. Adipose Tissue Biology. Adipose Tissue Biology
257
300
.
Evan Atlantis, Paul Fahey, Sean Martin, Peter O’Loughlin, Anne W. Taylor, Robert J. Adams, Zumin Shi & Gary Wittert. (2016) Predictive value of serum testosterone for type 2 diabetes risk assessment in men. BMC Endocrine Disorders 16:1.
Crossref
Crossref
Ali Al-Khazaali, Rohit Arora & Saad Muttar. (2016) Controversial Effects of Exogenous Testosterone on Cardiovascular Diseases. American Journal of Therapeutics 23:6, pages e1504-e1513.
Crossref
Crossref
Oluwadamilola Onasanya, Geetha Iyer, Eleanor Lucas, Dora Lin, Sonal Singh & G Caleb Alexander. (2016) Association between exogenous testosterone and cardiovascular events: an overview of systematic reviews. The Lancet Diabetes & Endocrinology 4:11, pages 943-956.
Crossref
Crossref
Alankar Tiwari & Anubha Srivastava. (2016) SERUM TESTOSTERONE IN MALES WITH NEWLY DIAGNOSED TYPE 2 DIABETES AND ITS ASSOCIATION WITH GLYCEMIC STATUS AND OTHER METABOLIC INDICES. Journal of Evidence Based Medicine and Healthcare 3:85, pages 4621-4626.
Crossref
Crossref
Rakesh Kumar Chaudhary, Bilal Haider Shamsi, Hui-ming Chen, Tan Tan, Kai-fa Tang & Jun-ping Xing. (2016) Risk factors for erectile dysfunction in patients with cardiovascular disease. Journal of International Medical Research 44:3, pages 718-727.
Crossref
Crossref
Ângela Castela & Carla Costa. (2016) Molecular mechanisms associated with diabetic endothelial–erectile dysfunction. Nature Reviews Urology 13:5, pages 266-274.
Crossref
Crossref
Jonathan G. Boucher, Shaimaa Ahmed & Ella Atlas. (2016) Bisphenol S Induces Adipogenesis in Primary Human Preadipocytes From Female Donors. Endocrinology 157:4, pages 1397-1407.
Crossref
Crossref
Kuldeep Chandel, Archit Gupta, Pallavi Agrawal & Kshitiz Nath. (2016) EVALUATION OF TESTOSTERONE DEFICIENCY IN PATIENTS OF TYPE 2 DIABETES MELLITUS. Journal of Evolution of Medical and Dental Sciences 5:25, pages 1317-1318.
Crossref
Crossref
Giovanni Corona, Vito A Giagulli, Elisa Maseroli, Linda Vignozzi, Antonio Aversa, Michael Zitzmann, Farid Saad, Edoardo Mannucci & Mario Maggi. (2016) THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study. European Journal of Endocrinology 174:3, pages R99-R116.
Crossref
Crossref
Mercè Fernández-Miró, Juan J. Chillarón & Juan Pedro-Botet. (2016) Déficit de testosterona, síndrome metabólico y diabetes mellitus. Medicina Clínica 146:2, pages 69-73.
Crossref
Crossref
Mercè Fernández-Miró, Juan J. Chillarón & Juan Pedro-Botet. (2016) Testosterone deficiency, metabolic syndrome and diabetes mellitus. Medicina Clínica (English Edition) 146:2, pages 69-73.
Crossref
Crossref
V. A. Giagulli, M. D. Carbone, M. I. Ramunni, B. Licchelli, G. De Pergola, C. Sabbà, E. Guastamacchia & V. Triggiani. (2015) Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism. Andrology 3:6, pages 1094-1103.
Crossref
Crossref
Isabel Errazuriz, Simmi Dube, Ananda Basu & Rita Basu. (2015) Effects of testosterone replacement on glucose and lipid metabolism. Cardiovascular Endocrinology 4:3, pages 95-99.
Crossref
Crossref
Geoff I. Hackett. (2015) Cardiometabolic effects of testosterone in older men. Cardiovascular Endocrinology 4:3, pages 108-113.
Crossref
Crossref
Shawn Riser Taylor, Lindsy M. Meadowcraft & Bobbie Williamson. (2015) Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 35:8, pages 780-792.
Crossref
Crossref
Giampaolo Niccoli, Domenico Milardi, Domenico D’Amario, Francesco Fracassi, Giuseppe Grande, Roberta Antonazzo Panico, Marco Roberto, Alessandro Mandurino Mirizzi, Giulia Canu, Laura De Marinis, Cinzia Carrozza, Alfredo Pontecorvi & Filippo Crea. (2014) Hypotestosteronemia is frequent in ST-elevation myocardial infarction patients and is associated with coronary microvascular obstruction. European Journal of Preventive Cardiology 22:7, pages 855-863.
Crossref
Crossref
D. M. Kelly & T. H. Jones. (2015) Testosterone and obesity. Obesity Reviews 16:7, pages 581-606.
Crossref
Crossref
Monika Gawałek & Joanna H. Sliwowska. (2015) Neuronal basis of reproductive dysfunctions associated with diet and alcohol: From the womb to adulthood. Reproductive Biology 15:2, pages 69-78.
Crossref
Crossref
C. Mary Schooling, Lin Xu & Jie Zhao. (2015) Debate: Testosterone Therapy Reduces Cardiovascular Risk in Men with Diabetes. Against the Motion. Current Cardiovascular Risk Reports 9:5.
Crossref
Crossref
Ecem Kaya, Suresh C. Sikka & Serap Gur. (2015) A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction. The Journal of Sexual Medicine 12:4, pages 856-875.
Crossref
Crossref
André Tchernof, Mohamed Fouad Mansour, Mélissa Pelletier, Marie-Michèle Boulet, Mélanie Nadeau & Van Luu-The. (2015) Updated survey of the steroid-converting enzymes in human adipose tissues. The Journal of Steroid Biochemistry and Molecular Biology 147, pages 56-69.
Crossref
Crossref
Marie Sinclair, Mathis Grossmann, Paul J Gow & Peter W Angus. (2015) Testosterone in men with advanced liver disease: Abnormalities and implications. Journal of Gastroenterology and Hepatology 30:2, pages 244-251.
Crossref
Crossref
Abraham Morgentaler, Martin M. Miner, Monica Caliber, Andre T. Guay, Mohit Khera & Abdulmaged M. Traish. (2015) Testosterone Therapy and Cardiovascular Risk: Advances and Controversies. Mayo Clinic Proceedings 90:2, pages 224-251.
Crossref
Crossref
Alper Sonmez, Cem Haymana, Aydogan Aydogdu, Serkan Tapan, Yalcin Basaran, Coskun Meric, Kamil Baskoy, Mustafa Dinc, Mahmut Yazici, Abdullah Taslipinar, Cem Barcin, Mahmut Ilker Yilmaz, Erol Bolu & Omer Azal. (2015) Endothelial dysfunction, insulin resistance and inflammation in congenital hypogonadism, and the effect of testosterone replacement. Endocrine Journal 62:7, pages 605-613.
Crossref
Crossref
Renata S. Auriemma, Mariano Galdiero, Pasquale Vitale, Luciana Granieri, Fabio Lo Calzo, Ciro Salzano, Lucia Ferreri, Claudia Pivonello, Federica Cariati, Giorgio Coppola, Cristina de Angelis, Annamaria Colao & Rosario Pivonello. (2015) Effect of Chronic Cabergoline Treatment and Testosterone Replacement on Metabolism in Male Patients with Prolactinomas. Neuroendocrinology 101:1, pages 66-81.
Crossref
Crossref
Leonardo Reis & Ricardo Miyaoka. 2015. Handbook of Fertility. Handbook of Fertility
221
226
.
Anusha Jayaraman, Daniella Lent-Schochet & Christian J Pike. (2014) Diet-induced obesity and low testosterone increase neuroinflammation and impair neural function. Journal of Neuroinflammation 11:1.
Crossref
Crossref
Mouna Zerradi, Julie Dereumetz, Marie-Michèle Boulet & André Tchernof. (2014) Androgens, body fat Distribution and Adipogenesis. Current Obesity Reports 3:4, pages 396-403.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Adverse health effects of testosterone deficiency (TD) in men. Steroids 88, pages 106-116.
Crossref
Crossref
Abdulmaged M. Traish. (2014) Outcomes of testosterone therapy in men with testosterone deficiency (TD): Part II. Steroids 88, pages 117-126.
Crossref
Crossref
Daniel M. Kelly, Joanne E. Nettleship, Samia Akhtar, Vakkat Muraleedharan, Donna J. Sellers, Jonathan C. Brooke, David S. McLaren, Kevin S. Channer & T. Hugh Jones. (2014) Testosterone suppresses the expression of regulatory enzymes of fatty acid synthesis and protects against hepatic steatosis in cholesterol-fed androgen deficient mice. Life Sciences 109:2, pages 95-103.
Crossref
Crossref
A. M. Traish, A. Haider, G. Doros & F. Saad. (2013) Long‐term testosterone therapy in hypogonadal men ameliorates elements of the metabolic syndrome: an observational, long‐term registry study. International Journal of Clinical Practice 68:3, pages 314-329.
Crossref
Crossref
K. Leisegang, A. Udodong, P. J. D. Bouic & R. R. Henkel. (2014) Effect of the metabolic syndrome on male reproductive function: a case-controlled pilot study. Andrologia 46:2, pages 167-176.
Crossref
Crossref
R D Stanworth, S Akhtar, K S Channer & T H Jones. (2014) The role of androgen receptor CAG repeat polymorphism and other factors which affect the clinical response to testosterone replacement in metabolic syndrome and type 2 diabetes: TIMES2 sub-study. European Journal of Endocrinology 170:2, pages 193-200.
Crossref
Crossref
Patricia S. Juang, Susan Peng, Kambiz Allehmazedeh, Ansal Shah, Andrea D. Coviello & Karen L. Herbst. (2014) Testosterone with Dutasteride, but Not Anastrazole, Improves Insulin Sensitivity in Young Obese Men: A Randomized Controlled Trial. The Journal of Sexual Medicine 11:2, pages 563-573.
Crossref
Crossref
Gaëtan Prévost, Florence Eas & Jean-Marc Kuhn. (2014) Testostérone plasmatique, obésité, syndrome métabolique et diabète. La Presse Médicale 43:2, pages 186-195.
Crossref
Crossref
Joo-Sung KimBong Sun KimJa Young JeonYong Jun ChoiYoon-Sok Chung. (2014) Testosterone Deficiency Associated with Poor Glycemic Control in Korean Male Diabetics. Endocrinology and Metabolism 29:3, pages 300.
Crossref
Crossref
Ahmad Haider, Aksam Yassin, Gheorghe Doros & Farid Saad. (2014) Effects of Long-Term Testosterone Therapy on Patients with “Diabesity”: Results of Observational Studies of Pooled Analyses in Obese Hypogonadal Men with Type 2 Diabetes. International Journal of Endocrinology 2014, pages 1-15.
Crossref
Crossref
G. Hackett, M. Kirby & A. J. Sinclair. (2014) Testosterone Deficiency, Cardiac Health, and Older Men. International Journal of Endocrinology 2014, pages 1-10.
Crossref
Crossref
Sunhyo Jeong. (2013) Effects of Testosterone on Adipose Tissue Metabolism. Journal of the Korea Institute of Information and Communication Engineering 17:12, pages 2995-3000.
Crossref
Crossref
. (2013) Dysfonction érectile. Canadian Journal of Diabetes 37, pages S648.
Crossref
Crossref
P M Willemse, J Burggraaf, N A T Hamdy & S Osanto. (2013) Reply: ‘Comment on Prevalence of the metabolic syndrome and cardiovascular disease risk in chemotherapy-treated testicular germ cell tumour survivors’. British Journal of Cancer 109:9, pages 2503-2504.
Crossref
Crossref
Leighton J. Seal. (2013) Male hypogonadism and testosterone replacement therapy. Medicine 41:10, pages 557-561.
Crossref
Crossref
Gerald Brock & William Harper. (2013) Dysfonction érectile. Canadian Journal of Diabetes 37, pages S528-S530.
Crossref
Crossref
Preethi M. Rao, Daniel M. Kelly & T. Hugh Jones. (2013) Testosterone and insulin resistance in the metabolic syndrome and T2DM in men. Nature Reviews Endocrinology 9:8, pages 479-493.
Crossref
Crossref
G. Corona, G. Rastrelli & M. Maggi. (2013) Diagnosis and treatment of late-onset hypogonadism: Systematic review and meta-analysis of TRT outcomes. Best Practice & Research Clinical Endocrinology & Metabolism 27:4, pages 557-579.
Crossref
Crossref
Daniel M Kelly & T Hugh Jones. (2013) Testosterone: a metabolic hormone in health and disease. Journal of Endocrinology 217:3, pages R25-R45.
Crossref
Crossref
. (2013) Erectile Dysfunction. Canadian Journal of Diabetes 37, pages S337.
Crossref
Crossref
Eric Wespes. (2013) Metabolic Syndrome and Hypogonadism. European Urology Supplements 12:2, pages 2-6.
Crossref
Crossref
Armand Zini & Naif Al-Hathal. 2013. Paternal Influences on Human Reproductive Success. Paternal Influences on Human Reproductive Success
116
128
.
Gerald Brock & William Harper. (2013) Erectile Dysfunction. Canadian Journal of Diabetes 37, pages S150-S152.
Crossref
Crossref
Gregory C. Mitchell & Wayne J.G. Hellstrom. 2013. Fertility Preservation in Male Cancer Patients. Fertility Preservation in Male Cancer Patients
80
93
.
. 2013. Fertility Preservation in Male Cancer Patients. Fertility Preservation in Male Cancer Patients
39
103
.
Hua Zhang, Yuanwu Liu, Li Wang, Zhen Li, Hongwen Zhang, Jihua Wu, Nafis Rahman, Yangdong Guo, Defa Li, Ning Li, Ilpo Huhtaniemi, Suk Ying Tsang, George F. Gao & Xiangdong Li. (2013) Differential effects of estrogen/androgen on the prevention of nonalcoholic fatty liver disease in the male rat. Journal of Lipid Research 54:2, pages 345-357.
Crossref
Crossref
Richard E. Scranton, Irwin Goldstein & Vera J. Stecher. (2013) Erectile Dysfunction Diagnosis and Treatment as a Means to Improve Medication Adherence and Optimize Comorbidity Management. The Journal of Sexual Medicine 10:2, pages 551-561.
Crossref
Crossref
Daniel J. Moskovic, Andre B. Araujo, Larry I. Lipshultz & Mohit Khera. (2013) The 20‐Year Public Health Impact and Direct Cost of Testosterone Deficiency in U.S. Men. The Journal of Sexual Medicine 10:2, pages 562-569.
Crossref
Crossref
Michał Rabijewski, Lucyna Papierska, Wojciech Zgliczyński & Paweł Piątkiewicz. (2013) The Incidence of Hypogonadotropic Hypogonadism in Type 2 Diabetic Men in Polish Population. BioMed Research International 2013, pages 1-6.
Crossref
Crossref
André Tchernof & Jean-Pierre Després. (2013) Pathophysiology of Human Visceral Obesity: An Update. Physiological Reviews 93:1, pages 359-404.
Crossref
Crossref
Andrew Collier, Sujoy Ghosh, Brian McGlynn & Graham Hollins. (2012) Prostate Cancer, Androgen Deprivation Therapy, Obesity, the Metabolic Syndrome, Type 2 Diabetes, and Cardiovascular Disease. American Journal of Clinical Oncology 35:5, pages 504-509.
Crossref
Crossref
Nevine Bahaa E. Soliman. (2012) Effect of chronic immobilization stress on the pancreatic structure and the possible protective role of testosterone administration in male albino rats. The Egyptian Journal of Histology 35:3, pages 448-457.
Crossref
Crossref
Janine T. Baer. (2012) Testosterone replacement therapy to improve health in older males. The Nurse Practitioner 37:8, pages 39-44.
Crossref
Crossref
G. Hackett. (2012) Testosterone and the heart. International Journal of Clinical Practice 66:7, pages 648-655.
Crossref
Crossref
Simon George Anderson, Adrian Heald, Novie Younger, Sumudu Bujawansa, Ram Prakash Narayanan, Alan McCulloch & Hugh Jones. (2012) Screening for hypogonadism in diabetes 2008/9: Results from the Cheshire Primary Care cohort. Primary Care Diabetes 6:2, pages 143-148.
Crossref
Crossref
Giovanni Corona, Giulia Rastrelli, Giancarlo Balercia, Francesco Lotti, Alessandra Sforza, Matteo Monami, Gianni Forti, Edoardo Mannucci & Mario Maggi. (2012) Hormonal Association and Sexual Dysfunction in Patients with Impaired Fasting Glucose: A Cross-Sectional and Longitudinal Study. The Journal of Sexual Medicine 9:6, pages 1669-1680.
Crossref
Crossref
X. Wei, G. Peng, S. Zheng & X. Wu. (2012) Differentiation of umbilical cord mesenchymal stem cells into steroidogenic cells in comparison to bone marrow mesenchymal stem cells. Cell Proliferation 45:2, pages 101-110.
Crossref
Crossref
Richard K. Lee, Bilal Chughtai, Alexis E. Te & Steven A. Kaplan. (2012) Sexual Function in Men with Metabolic Syndrome. Urologic Clinics of North America 39:1, pages 53-62.
Crossref
Crossref
Martin M. Miner. (2012) Men’s Health in Primary Care: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk. Urologic Clinics of North America 39:1, pages 1-23.
Crossref
Crossref
Akl C. Fahed, Joanna M. Gholmieh & Sami T. Azar. (2012) Connecting the Lines between Hypogonadism and Atherosclerosis. International Journal of Endocrinology 2012, pages 1-12.
Crossref
Crossref
Aldo Clerico, Alberto Giannoni, Simona Vittorini & Michele Emdin. (2011) The paradox of low BNP levels in obesity. Heart Failure Reviews 17:1, pages 81-96.
Crossref
Crossref
Alain Veilleux & André Tchernof. 2012. Adipose Tissue Biology. Adipose Tissue Biology
123
166
.
Rajib K Bhattacharya, Mohit Khera, Gary Blick, Harvey Kushner, Dat Nguyen & Martin M Miner. (2011) Effect of 12 months of testosterone replacement therapy on metabolic syndrome components in hypogonadal men: data from the Testim Registry in the US (TRiUS). BMC Endocrine Disorders 11:1.
Crossref
Crossref
G. Corona, M. Monami, G. Rastrelli, A. Aversa, A. Sforza, A. Lenzi, G. Forti, E. Mannucci & M. Maggi. (2011) Type 2 diabetes mellitus and testosterone: a meta-analysis study. International Journal of Andrology 34:6pt1, pages 528-540.
Crossref
Crossref
Farid Saad, Antonio Aversa, Andrea M Isidori, Livia Zafalon, Michael Zitzmann & Louis Gooren. (2011) Onset of effects of testosterone treatment and time span until maximum effects are achieved. European Journal of Endocrinology 165:5, pages 675-685.
Crossref
Crossref
Bilal Chughtai, Richard K. Lee, Alexis E. Te & Steven A. Kaplan. (2011) Metabolic syndrome and sexual dysfunction. Current Opinion in Urology 21:6, pages 514-518.
Crossref
Crossref
Angela Castela, Pedro Vendeira & Carla Costa. (2011) Testosterone, Endothelial Health, and Erectile Function. ISRN Endocrinology 2011, pages 1-7.
Crossref
Crossref
Carlo Foresta, Giacomo Strapazzon, Luca De Toni, Lisa Gianesello, Andrea Bruttocao, Alessandro Scarda, Mario Plebani & Andrea Garolla. (2011) Androgens modulate osteocalcin release by human visceral adipose tissue. Clinical Endocrinology 75:1, pages 64-69.
Crossref
Crossref
Akira Tsujimura & Norio Nonomura. (2011) Recent topics related to testosterone deficiency syndrome in Japan. Asian Journal of Andrology 13:4, pages 558-562.
Crossref
Crossref
Gina J. Ryan & Lynetta J. Jobe. (2011) Age-Related Androgen Deficiency and Type 2 Diabetes. Journal of Pharmacy Practice 24:3, pages 316-322.
Crossref
Crossref
A Sonmez, C Haymana, E Bolu, A Aydogdu, S Tapan, M Serdar, B Altun, C Barcin, A Taslipinar, C Meric, G Uckaya & M Kutlu. (2011) Metabolic syndrome and the effect of testosterone treatment in young men with congenital hypogonadotropic hypogonadism. European Journal of Endocrinology 164:5, pages 759-764.
Crossref
Crossref
Sazan Rasul, Aysegul Ilhan, Marie Helene Reiter, Sabina Baumgartner-Parzer & Alexandra Kautzky-Willer. (2011) Relations of Adiponectin to Levels of Metabolic Parameters and Sexual Hormones in Elderly Type 2 Diabetic Patients. Gender Medicine 8:2, pages 93-102.
Crossref
Crossref
Genovefa Kolovou, Helen Bilianou, Apostolia Marvaki & Dimitri P. Mikhailidis. (2010) Aging Men and Lipids. American Journal of Men's Health 5:2, pages 152-165.
Crossref
Crossref
J. S. Brand, I. van der Tweel, D. E. Grobbee, M. H. Emmelot-Vonk & Y. T. van der Schouw. (2010) Testosterone, sex hormone-binding globulin and the metabolic syndrome: a systematic review and meta-analysis of observational studies. International Journal of Epidemiology 40:1, pages 189-207.
Crossref
Crossref
Jin Wook KimJe Jong KimDu Geon Moon. (2011) Effects of Androgen on the Cardiovascular System in the Aging Male. Korean Journal of Andrology 29:1, pages 10.
Crossref
Crossref
Jin Wook KimDu Geon Moon. (2011) Diagnosis and Treatment of Sexual Dysfunctions in Late-Onset Hypogonadism. Korean Journal of Urology 52:11, pages 725.
Crossref
Crossref
Glenn R. Cunningham & Shivani M. Toma. (2011) Why Is Androgen Replacement in Males Controversial?. The Journal of Clinical Endocrinology & Metabolism 96:1, pages 38-52.
Crossref
Crossref
Farid Saad & Louis J. Gooren. (2011) The Role of Testosterone in the Etiology and Treatment of Obesity, the Metabolic Syndrome, and Diabetes Mellitus Type 2. Journal of Obesity 2011, pages 1-10.
Crossref
Crossref
Paolo Verze & Vincenzo Mirone. 2011. Practical Urology: Essential Principles and Practice. Practical Urology: Essential Principles and Practice
219
238
.
Mathew C. Raynor, Michael R. Pinsky, Arthi Chawla & Wayne J. G. Hellstrom. 2011. Cancer and Sexual Health. Cancer and Sexual Health
195
215
.
Vakkat Muraleedharan & T. Hugh Jones. (2010) Review: Testosterone and the metabolic syndrome. Therapeutic Advances in Endocrinology and Metabolism 1:5, pages 207-223.
Crossref
Crossref
Antonio Aversa, R. Bruzziches, D. Francomano, G. Spera & A. Lenzi. (2014) Efficacy and safety of two different testosterone undecanoate formulations in hypogonadal men with metabolic syndrome. Journal of Endocrinological Investigation 33:11, pages 776-783.
Crossref
Crossref
Svetlana Y. Kalinchenko, Yuliya A. Tishova, George J. Mskhalaya, Louis J. G. Gooren, Erik J. Giltay & Farid Saad. (2010) Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double‐blinded placebo‐controlled Moscow study. Clinical Endocrinology 73:5, pages 602-612.
Crossref
Crossref
Geniece M. LehmannCollynn F. WoellerStephen J. PollockCharles W. O'LoughlinShikha GuptaSteven E. FeldonRichard P. Phipps. (2010) Novel anti-adipogenic activity produced by human fibroblasts. American Journal of Physiology-Cell Physiology 299:3, pages C672-C681.
Crossref
Crossref
T. Hugh JONES. (2010) Effects of testosterone on Type 2 diabetes and components of the metabolic syndrome. Journal of Diabetes 2:3, pages 146-156.
Crossref
Crossref
Yung-Chin Lee, Chia-Chu Liu, Chun-Nung Huang, Wei-Ming Li, Wen-Jeng Wu, Hsin-Chih Yeh, Chii-Jye Wang, Chun-Hsiung Huang & Shu-Pin Huang. (2010) The Potential Impact of Metabolic Syndrome on Erectile Dysfunction in Aging Taiwanese Males. The Journal of Sexual Medicine 7:9, pages 3127-3134.
Crossref
Crossref
T.H. Jones. (2010) Testosterone deficiency: a risk factor for cardiovascular disease?. Trends in Endocrinology & Metabolism 21:8, pages 496-503.
Crossref
Crossref
Raju A. Gopal, Nikita Bothra, Shrikrishna V. Acharya, Hosahithlu K. Ganesh, Tushar R. Bandgar, Padma S. Menon & Nalini S. Shah. (2010) Treatment of Hypogonadism with Testosterone in Patients with Type 2 Diabetes Mellitus. Endocrine Practice 16:4, pages 570-576.
Crossref
Crossref
Erik J. Giltay, Yuliya A. Tishova, George J. Mskhalaya, Louis J.G. Gooren, Farid Saad & Svetlana Y. Kalinchenko. (2010) Effects of Testosterone Supplementation on Depressive Symptoms and Sexual Dysfunction in Hypogonadal Men with the Metabolic Syndrome. The Journal of Sexual Medicine 7:7, pages 2572-2582.
Crossref
Crossref
Graeme P. Williams. (2010) The role of oestrogen in the pathogenesis of obesity, type 2 diabetes, breast cancer and prostate disease. European Journal of Cancer Prevention 19:4, pages 256-271.
Crossref
Crossref
Michael R. Pinsky & Wayne J. G. Hellstrom. (2010) Hypogonadism, ADAM, and hormone replacement. Therapeutic Advances in Urology 2:3, pages 99-104.
Crossref
Crossref
Mathis Grossmann, Emily J Gianatti & Jeffrey D Zajac. (2010) Testosterone and type 2 diabetes. Current Opinion in Endocrinology, Diabetes & Obesity 17:3, pages 247-256.
Crossref
Crossref
Alessandra Cornoldi, Giuseppe Caminiti, Giuseppe Marazzi, Cristiana Vitale, Roberto Patrizi, Maurizio Volterrani, Marco Miceli, Massimo Fini, Giovanni Spera & Giuseppe Rosano. (2010) Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease. International Journal of Cardiology 142:1, pages 50-55.
Crossref
Crossref
Pablo Knoblovits, Pablo R. Costanzo, Gastón J. Rey Valzacchi, Guillermo Gueglio, Alberto O. Layus, Andrea E. Kozak, Marta I. Balzaretti & León E. Litwak. (2013) Erectile Dysfunction, Obesity, Insulin Resistance, and Their Relationship With Testosterone Levels in Eugonadal Patients in an Andrology Clinic Setting. Journal of Andrology 31:3, pages 263-270.
Crossref
Crossref
Torkel Vikan, Henrik Schirmer, Inger Njølstad & Johan Svartberg. (2010) Low testosterone and sex hormone-binding globulin levels and high estradiol levels are independent predictors of type 2 diabetes in men. European Journal of Endocrinology 162:4, pages 747-754.
Crossref
Crossref
Jacques Buvat, Mario Maggi, Louis Gooren, Andre T. Guay, Joel Kaufman, Abraham Morgentaler, Claude Schulman, Hui Meng Tan, Luiz Otavio Torres, Aksam Yassin & Michael Zitzmann. (2010) Endocrine Aspects of Male Sexual Dysfunctions. The Journal of Sexual Medicine 7:4, pages 1627-1656.
Crossref
Crossref
Karine Blouin, Mélanie Nadeau, Martin Perreault, Alain Veilleux, Renée Drolet, Picard Marceau, Jacques Mailloux, Van Luu‐The & André Tchernof. (2010) Effects of androgens on adipocyte differentiation and adipose tissue explant metabolism in men and women. Clinical Endocrinology 72:2, pages 176-188.
Crossref
Crossref
John R.B. Perry, Michael N. Weedon, Claudia Langenberg, Anne U. Jackson, Valeriya Lyssenko, Thomas Sparsø, Gudmar Thorleifsson, Harald Grallert, Luigi Ferrucci, Marcello Maggio, Giuseppe Paolisso, Mark Walker, Colin N.A. Palmer, Felicity Payne, Elizabeth Young, Christian Herder, Narisu Narisu, Mario A. Morken, Lori L. Bonnycastle, Katharine R. Owen, Beverley Shields, Beatrice Knight, Amanda Bennett, Christopher J. Groves, Aimo Ruokonen, Marjo Riitta Jarvelin, Ewan Pearson, Laura Pascoe, Ele Ferrannini, Stefan R. Bornstein, Heather M. Stringham, Laura J. Scott, Johanna Kuusisto, Peter Nilsson, Malin Neptin, Anette P. Gjesing, Charlotta Pisinger, Torsten Lauritzen, Annelli Sandbaek, Mike Sampson, MAGIC, Ele Zeggini, Cecilia M. Lindgren, Valgerdur Steinthorsdottir, Unnur Thorsteinsdottir, Torben Hansen, Peter Schwarz, Thomas Illig, Markku Laakso, Kari Stefansson, Andrew D. Morris, Leif Groop, Oluf Pedersen, Michael Boehnke, Inês Barroso, Nicholas J. Wareham, Andrew T. Hattersley, Mark I. McCarthy & Timothy M. Frayling. (2010) Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes. Human Molecular Genetics 19:3, pages 535-544.
Crossref
Crossref
Sherita Hill Golden. 2010. Principles of Gender-Specific Medicine. Principles of Gender-Specific Medicine
679
693
.
Sandra Filippi, Linda Vignozzi, Annamaria Morelli, Aravinda K. Chavalmane, Erica Sarchielli, Benedetta Fibbi, Farid Saad, Peter Sandner, Peggy Ruggiano, Gabriella B. Vannelli, Edoardo Mannucci & Mario Maggi. (2009) Testosterone Partially Ameliorates Metabolic Profile and Erectile Responsiveness to PDE5 Inhibitors in an Animal Model of Male Metabolic Syndrome. The Journal of Sexual Medicine 6:12, pages 3274-3288.
Crossref
Crossref
G. Corona, E. Mannucci, G. Forti & M. Maggi. (2009) Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases. International Journal of Andrology 32:6, pages 587-598.
Crossref
Crossref
Michael Zitzmann. (2009) Testosterone deficiency, insulin resistance and the metabolic syndrome. Nature Reviews Endocrinology 5:12, pages 673-681.
Crossref
Crossref
T. Hugh Jones & Farid Saad. (2009) The effects of testosterone on risk factors for, and the mediators of, the atherosclerotic process. Atherosclerosis 207:2, pages 318-327.
Crossref
Crossref
Displaying 200 of 268 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list